Free radicals and antioxidants in cardiovascular diseases

被引:37
作者
Abrescia, Paolo [1 ]
Golino, Paolo [2 ]
机构
[1] Univ Naples Federico II, Dept Gen & Environm Physiol, Physiol Organs & Syst, Via Mezzocannone 8, I-80134 Naples, Italy
[2] Univ Naples 2, Dept Cardiothorac & Resp Sci, Div Cardiol, AO Monaldi,Cardiovasc Dis, I-80131 Naples, Italy
关键词
antioxidants; cardiovascular diseases; endothelial dysfunction; gene therapy; nitric oxide; nitrosothiols; oxidative stress;
D O I
10.1586/14779072.3.1.159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It has been demonstrated that redox homeostasis is important in the pathophysiology of several human diseases, including cardiovascular diseases. In this respect, genetic polymorphism, nutritional and environmental factors, age, lifestyle and physical activity may account for variable antioxidant defenses, which may be more or less effective at counteracting oxidative damage. Since accumulating oxidative damage may be associated with several pathologic conditions, including different cardiovascular diseases, prevention of oxidative stress appears to be a promising approach to improve such diseases. Exercise training, diets rich in antioxidants and a good control of blood glucose and lipid levels help to strengthen the physiologic antioxidant defense system, perhaps coupled to drugs capable of increasing the nitric oxide bioavailability and decreasing superoxide production. Within the next few years other therapeutic approaches will be available, such as gene therapy, which will prove to be even more effective but devoid of several important systemic side effects.
引用
收藏
页码:159 / 171
页数:13
相关论文
共 102 条
[1]   Insulin signaling in the vasculature [J].
Begum, N .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2003, 8 :S796-S804
[2]   Cardiac mitochondrial NADP+-isocitrate dehydrogenase is inactivated through 4-hydroxynonenal adduct formation -: An event that precedes hypertrophy development [J].
Benderdour, M ;
Charron, G ;
deBlois, D ;
Comte, B ;
Des Rosiers, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (46) :45154-45159
[3]   NITRIC-OXIDE - A PHYSIOLOGICAL MESSENGER MOLECULE [J].
BREDT, DS ;
SNYDER, SH .
ANNUAL REVIEW OF BIOCHEMISTRY, 1994, 63 :175-195
[4]   Antioxidant vitamins and lipid therapy - End of a long romance? [J].
Brown, BG ;
Cheung, MC ;
Lee, AC ;
Zhao, XQ ;
Chait, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (10) :1535-1546
[5]   NEGATIVE FEEDBACK-REGULATION OF ENDOTHELIAL-CELL FUNCTION BY NITRIC-OXIDE [J].
BUGA, GM ;
GRISCAVAGE, JM ;
ROGERS, NE ;
IGNARRO, LJ .
CIRCULATION RESEARCH, 1993, 73 (05) :808-812
[6]   The vascular NAD(P)H oxidases as therapeutic targets cardiovascular diseases [J].
Cai, H ;
Griendling, KK ;
Harrison, DG .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (09) :471-478
[7]   Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients [J].
Cardillo, C ;
Kilcoyne, CM ;
Cannon, RO ;
Quyyumi, AA ;
Panza, JA .
HYPERTENSION, 1997, 30 (01) :57-63
[8]  
Channon KM, 2002, J PHYSIOL PHARMACOL, V53, P515
[9]   HEMATOCRIT, BLOOD-PRESSURE, AND HYPERTENSION - THE GUBBIO POPULATION STUDY [J].
CIRILLO, M ;
LAURENZI, M ;
TREVISAN, M ;
STAMLER, J .
HYPERTENSION, 1992, 20 (03) :319-326
[10]   Antioxidant vitamins and risk of cardiovascular disease. Review of large-scale randomised trials [J].
Clarke, R ;
Armitage, J .
CARDIOVASCULAR DRUGS AND THERAPY, 2002, 16 (05) :411-415